iBio IBIO
NASDAQ IBIO
$1.12 +0.01 (+0.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

iBio (IBIO) Selling, General & Administrative (2010 - 2026)

Updated

iBio's Selling, General & Administrative was -$2.18 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $2.17 million a year earlier.

Analysis

iBio (IBIO) Selling, General & Administrative (2010 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Selling, General & Administrative at iBio came in at $10.6 million, down 0.9% from FY2025.

  • Selling, General & Administrative has now declined for five consecutive fiscal years, with a five-year compound annual growth rate of -13.6% (FY2021 to FY2026).
  • In earlier fiscal years, Selling, General & Administrative was $10.69 million in FY2025 (-8.4%), $11.67 million in FY2024 (-38.6%), $19.02 million in FY2023 (-12.6%) and $21.75 million in FY2022 (-1.3%).
  • The fiscal Q4 2026 figure marks the lowest quarterly Selling, General & Administrative in data going back to fiscal Q1 2011.
  • Compared with a year earlier, Selling, General & Administrative was higher in three of the last seven quarters, with growth averaging 17.0%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was fiscal Q2 2026 (growth of 88.4%); the worst was fiscal Q4 2023 (a decline of 62.1%).
  • Per Business Quant data, IBIO's Selling, General & Administrative in the three fiscal quarters before Q4 2026 was $5.11 million (Q3 2026), $5.17 million (Q2 2026) and $2.5 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 iBio 116.55 Mn 116.55 Mn - -2.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.18 Mn
Mar 31, 2026 5.11 Mn
Dec 31, 2025 5.17 Mn
Sep 30, 2025 2.50 Mn
Jun 30, 2025 2.17 Mn
Mar 31, 2025 2.97 Mn
Dec 31, 2024 2.74 Mn
Sep 30, 2024 2.80 Mn
Jun 30, 2024 2.44 Mn
Mar 31, 2024 2.72 Mn
Dec 31, 2023 2.96 Mn
Sep 30, 2023 3.55 Mn
Jun 30, 2023 2.61 Mn
Mar 31, 2023 3.53 Mn
Dec 31, 2022 7.79 Mn
Sep 30, 2022 5.09 Mn
Jun 30, 2022 6.89 Mn
Mar 31, 2022 5.32 Mn
Dec 31, 2021 5.37 Mn
Sep 30, 2021 4.18 Mn
API Access

iBio Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IBIO&period=max&api_key=YOUR_API_KEY